WO2003020711A1 - Composes dithiazole, inhibiteurs de metalloprotease matricielle et preparations a usage externe pour la peau - Google Patents
Composes dithiazole, inhibiteurs de metalloprotease matricielle et preparations a usage externe pour la peau Download PDFInfo
- Publication number
- WO2003020711A1 WO2003020711A1 PCT/JP2002/008649 JP0208649W WO03020711A1 WO 2003020711 A1 WO2003020711 A1 WO 2003020711A1 JP 0208649 W JP0208649 W JP 0208649W WO 03020711 A1 WO03020711 A1 WO 03020711A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- skin
- external preparations
- compounds
- matrix metalloprotease
- metalloprotease inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Birds (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/487,411 US7348017B2 (en) | 2001-08-28 | 2002-08-28 | Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin |
EP02772819A EP1422224B1 (en) | 2001-08-28 | 2002-08-28 | Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin |
KR1020047001888A KR100911092B1 (ko) | 2001-08-28 | 2002-08-28 | 디티아졸 화합물 및 매트릭스 메탈로프로테아제 활성저해제, 피부외용제 |
DE60224203T DE60224203T2 (de) | 2001-08-28 | 2002-08-28 | DITHIAZOLVERBINDUNGEN, MATRIX-METALLOPROTEASE-INHIBITOREN UND ZUBEREITUNGEN FÜR DIE ÄUßERLICHE ANWENDUNG AUF DER HAUT |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001258066A JP4825375B2 (ja) | 2001-08-28 | 2001-08-28 | ジチアゾール化合物及びマトリックスメタロプロテアーゼ活性阻害剤、皮膚外用剤 |
JP2001-258066 | 2001-08-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003020711A1 true WO2003020711A1 (fr) | 2003-03-13 |
Family
ID=19085645
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2002/008649 WO2003020711A1 (fr) | 2001-08-28 | 2002-08-28 | Composes dithiazole, inhibiteurs de metalloprotease matricielle et preparations a usage externe pour la peau |
Country Status (7)
Country | Link |
---|---|
US (1) | US7348017B2 (ja) |
EP (1) | EP1422224B1 (ja) |
JP (1) | JP4825375B2 (ja) |
KR (1) | KR100911092B1 (ja) |
CN (1) | CN1319957C (ja) |
DE (1) | DE60224203T2 (ja) |
WO (1) | WO2003020711A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010016681A3 (en) * | 2008-08-04 | 2010-06-03 | Snu R&Db Foundation | Pharmaceutical composition containing 1,2-dithiolthione derivative for preventing or treating disease caused by overexpression of lxr-alpha |
US20120064060A1 (en) * | 2004-06-23 | 2012-03-15 | Ono Pharmaceutical Co., Ltd. | Compound having s1p receptor binding potency and use thereof |
WO2012049153A1 (en) | 2010-10-12 | 2012-04-19 | Boehringer Ingelheim International Gmbh | Process for manufacturing dihydropteridinones and intermediates thereof |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITRE20010042A1 (it) * | 2001-04-24 | 2002-10-24 | Corghi Spa | Dispositivo sollevatore per macchine smontagomme |
KR101127390B1 (ko) | 2003-04-15 | 2012-03-23 | 웰스태트 테러퓨틱스 코포레이션 | 대사 질환의 치료용 화합물 |
CA2561741C (en) * | 2004-04-05 | 2016-09-27 | Alnylam Pharmaceuticals, Inc. | Processes and reagents for oligonucleotide synthesis and purification |
CA2585276A1 (en) * | 2004-10-29 | 2006-06-08 | Merck & Co., Inc. | N-(pyridin-3-yl)-2-phenylbutanamides as androgen receptor modulators |
BRPI0615948A2 (pt) * | 2005-09-07 | 2011-05-31 | Plexxikon Inc | composto ativo de ppar, sua composição, seu kit e seu uso |
US20090203851A1 (en) * | 2006-06-02 | 2009-08-13 | Dsm Ip Assets B.V. | Process for the Preparation of a Hydroxy-Aromatic Resin: Hydroxy-Aromatic Resin, and Modification Thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3753908A (en) * | 1971-08-30 | 1973-08-21 | Chevron Res | Oxidation inhibited lubricating oil compositions with extreme pressure properties |
DE2228364A1 (de) * | 1972-06-10 | 1973-12-20 | Bergwerksverband Gmbh | Verfahren zur herstellung von 3-acylamino-1,2,4-dithiazolin-5-thionen (acylxanthanwasserstoffe) |
WO1995019956A1 (en) * | 1994-01-20 | 1995-07-27 | British Biotech Pharmaceuticals Limited | Metalloproteinase inhibitors |
WO1996040745A2 (en) * | 1995-06-07 | 1996-12-19 | Proscript, Inc. | Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases |
WO1997040031A1 (en) * | 1996-04-23 | 1997-10-30 | Pharmacia & Upjohn Company | Thiadiazolyl(thio)ureas useful as matrix metalloprotease inhibitors |
WO1998054198A1 (en) * | 1997-05-30 | 1998-12-03 | Hybridon, Inc. | Novel sulfur transfer reagents for oligonucleotide synthesis |
WO1999032111A1 (en) * | 1997-12-22 | 1999-07-01 | Bayer Corporation | INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5830869A (en) * | 1996-06-21 | 1998-11-03 | Mitchell; Mark Allen | Thiadiazole amide MMP inhibitors |
DE69716449T2 (de) | 1996-08-28 | 2003-08-07 | Procter & Gamble | Substituierte zyklische amine als metalloproteaseinhibitoren |
-
2001
- 2001-08-28 JP JP2001258066A patent/JP4825375B2/ja not_active Expired - Fee Related
-
2002
- 2002-08-28 CN CNB028171039A patent/CN1319957C/zh not_active Expired - Fee Related
- 2002-08-28 DE DE60224203T patent/DE60224203T2/de not_active Expired - Lifetime
- 2002-08-28 EP EP02772819A patent/EP1422224B1/en not_active Expired - Fee Related
- 2002-08-28 KR KR1020047001888A patent/KR100911092B1/ko not_active IP Right Cessation
- 2002-08-28 WO PCT/JP2002/008649 patent/WO2003020711A1/ja active IP Right Grant
- 2002-08-28 US US10/487,411 patent/US7348017B2/en not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3753908A (en) * | 1971-08-30 | 1973-08-21 | Chevron Res | Oxidation inhibited lubricating oil compositions with extreme pressure properties |
DE2228364A1 (de) * | 1972-06-10 | 1973-12-20 | Bergwerksverband Gmbh | Verfahren zur herstellung von 3-acylamino-1,2,4-dithiazolin-5-thionen (acylxanthanwasserstoffe) |
WO1995019956A1 (en) * | 1994-01-20 | 1995-07-27 | British Biotech Pharmaceuticals Limited | Metalloproteinase inhibitors |
WO1996040745A2 (en) * | 1995-06-07 | 1996-12-19 | Proscript, Inc. | Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases |
WO1997040031A1 (en) * | 1996-04-23 | 1997-10-30 | Pharmacia & Upjohn Company | Thiadiazolyl(thio)ureas useful as matrix metalloprotease inhibitors |
WO1998054198A1 (en) * | 1997-05-30 | 1998-12-03 | Hybridon, Inc. | Novel sulfur transfer reagents for oligonucleotide synthesis |
WO1999032111A1 (en) * | 1997-12-22 | 1999-07-01 | Bayer Corporation | INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS |
Non-Patent Citations (1)
Title |
---|
See also references of EP1422224A4 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120064060A1 (en) * | 2004-06-23 | 2012-03-15 | Ono Pharmaceutical Co., Ltd. | Compound having s1p receptor binding potency and use thereof |
US8653305B2 (en) * | 2004-06-23 | 2014-02-18 | Ono Pharmaceutical Co., Ltd. | Compound having S1P receptor binding potency and use thereof |
WO2010016681A3 (en) * | 2008-08-04 | 2010-06-03 | Snu R&Db Foundation | Pharmaceutical composition containing 1,2-dithiolthione derivative for preventing or treating disease caused by overexpression of lxr-alpha |
US9370504B2 (en) | 2008-08-04 | 2016-06-21 | Snu R&Db Foundation | Pharmaceutical composition containing 1,2-dithiolthione derivative for preventing or treating disease caused by overexpression of LXR-α |
WO2012049153A1 (en) | 2010-10-12 | 2012-04-19 | Boehringer Ingelheim International Gmbh | Process for manufacturing dihydropteridinones and intermediates thereof |
Also Published As
Publication number | Publication date |
---|---|
KR20040032149A (ko) | 2004-04-14 |
EP1422224B1 (en) | 2007-12-19 |
DE60224203D1 (de) | 2008-01-31 |
US20040236111A1 (en) | 2004-11-25 |
CN1549809A (zh) | 2004-11-24 |
JP2003064065A (ja) | 2003-03-05 |
JP4825375B2 (ja) | 2011-11-30 |
CN1319957C (zh) | 2007-06-06 |
US7348017B2 (en) | 2008-03-25 |
EP1422224A4 (en) | 2005-11-09 |
KR100911092B1 (ko) | 2009-08-06 |
DE60224203T2 (de) | 2008-12-04 |
EP1422224A1 (en) | 2004-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ337298A (en) | N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors | |
MXPA04008806A (es) | Nuevos inhibidores de la histona desacetilasa. | |
PL371100A1 (en) | Sulfonylamino-derivatives as novel inhibitors of histone deacetylase | |
PL370982A1 (en) | Carbonylamino-derivatives as novel inhibitors of histone deacetylase | |
PL371036A1 (en) | Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase | |
PL370990A1 (en) | Sulfonyl-derivatives as novel inhibitors of histone deacetylase | |
NO20051695L (no) | Nye spirokondenserte kinazolinoner og deres anvendelse som fosfodiestereaseinbibitorer | |
TW200420542A (en) | A compound having TGF β inhibition activity and a medicinal composition containing the same | |
WO2006010749A3 (en) | Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase | |
WO2005061458A3 (en) | Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs | |
CA2336412A1 (en) | Medicament for treatment of diabetes | |
WO2007033039A3 (en) | Proteasome inhibiting beta lactam compounds | |
WO2003020711A1 (fr) | Composes dithiazole, inhibiteurs de metalloprotease matricielle et preparations a usage externe pour la peau | |
WO2004014868A8 (en) | Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors | |
HK1081194A1 (en) | 6-amino-1h-indazole compounds as phosphodiesterase4 inhibitors, pharmaceutical compositions compris ing the same, and use thereof | |
WO2003016248A3 (en) | Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace) | |
WO2003055856A3 (en) | BICYCLIC LACTAM DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE) | |
WO2004062562A3 (en) | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof | |
WO2003022801A1 (fr) | Derives d'acide hydroxamique inverse | |
IL161843A (en) | Derivatives of 2-amino-4-pyridylmethyl-thiazoline for the preparation of medicaments for use as inhibitors of inducible no-synthase | |
WO2005058841A3 (en) | Hiv protease inhibiting compounds | |
NO20050766L (no) | Sulfonylpiperidinderivater som inneholder en aryl- eller heteroarylgruppe til anvendelse som matriksmetalloproteinaseinhibitor | |
ATE250610T1 (de) | Kaliumkanal-blockierende mittel | |
EP1295880A4 (en) | IMIDAZOLE DERIVATIVES OR SALTS THEREOF, AND MEDICINAL PRODUCTS CONTAINING DERIVATIVES OR SALTS | |
EP1403268A4 (en) | FLUORESCENT PROBES FOR ZINC |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CN KR US Kind code of ref document: A1 Designated state(s): CN KR |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FR GB GR IE IT LU MC NL PT SE SK TR Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1020047001888 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10487411 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20028171039 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002772819 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002772819 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 2002772819 Country of ref document: EP |